CVE-2026-21980: Oracle Life Sciences SQL Injection Flaw

CVE-2026-21980 Overview

CVE-2026-21980 is a vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications, specifically affecting the Platform component. This easily exploitable flaw allows an unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful exploitation can result in unauthorized update, insert, or delete access to some accessible data, as well as unauthorized read access to a subset of accessible data within the application.

Critical Impact

Unauthenticated attackers can remotely access and modify sensitive healthcare data in Oracle Life Sciences Central Coding without requiring any privileges or user interaction.

Affected Products

• Oracle Life Sciences Central Coding version 7.0.1.0
• Oracle Health Sciences Applications (Platform component)

Discovery Timeline

• January 20, 2026 - CVE-2026-21980 published to NVD
• January 20, 2026 - Last updated in NVD database

Technical Details for CVE-2026-21980

Vulnerability Analysis

This vulnerability affects the Platform component of Oracle Life Sciences Central Coding, a critical application used in healthcare and life sciences environments for medical coding operations. The flaw allows unauthenticated attackers to access the system remotely over HTTP without requiring any privileges or user interaction.

The vulnerability impacts both data confidentiality and integrity. Attackers can gain unauthorized read access to a subset of data stored within the application, potentially exposing sensitive healthcare and life sciences information. Additionally, the flaw enables unauthorized modification capabilities, allowing attackers to insert, update, or delete certain accessible data records.

The ease of exploitation combined with the network-accessible attack surface makes this vulnerability particularly concerning for organizations running Oracle Life Sciences Central Coding in production environments, especially those exposed to untrusted networks.

Root Cause

The vulnerability stems from insufficient access control mechanisms within the Platform component of Oracle Life Sciences Central Coding. The application fails to properly authenticate and authorize incoming HTTP requests, allowing unauthenticated users to perform operations that should require proper credentials. This broken access control issue enables attackers to bypass security controls and directly interact with protected data resources.

Attack Vector

The attack vector is network-based, requiring only HTTP access to the vulnerable Oracle Life Sciences Central Coding instance. An attacker does not need any prior authentication or privileges to exploit this vulnerability. The attack can be conducted remotely without any user interaction, making it suitable for automated exploitation at scale.

Potential attack scenarios include:

1. An external attacker scanning for exposed Oracle Life Sciences Central Coding instances
2. An internal threat actor accessing the application from within the corporate network
3. Automated scripts targeting vulnerable deployments to extract or manipulate healthcare data

The vulnerability can be exploited by crafting malicious HTTP requests to the Platform component endpoints that lack proper access controls. For detailed technical information, refer to the Oracle Security Alert January 2026.

Detection Methods for CVE-2026-21980

Indicators of Compromise

• Unusual HTTP requests to Oracle Life Sciences Central Coding Platform endpoints from unauthenticated sources
• Unexpected data modifications or insertions in Oracle Life Sciences Central Coding database tables
• Anomalous read access patterns to sensitive data within the application
• HTTP access logs showing requests to protected resources without associated authentication events

Detection Strategies

• Deploy web application firewall (WAF) rules to monitor and alert on suspicious HTTP traffic patterns targeting Oracle Life Sciences Central Coding
• Enable comprehensive audit logging within Oracle Life Sciences Central Coding to track all data access and modification events
• Implement intrusion detection system (IDS) signatures to identify exploitation attempts against known Oracle vulnerabilities
• Configure SIEM correlation rules to detect unauthenticated access attempts followed by data retrieval or modification activities

Monitoring Recommendations

• Monitor HTTP access logs for requests to the Platform component from external or untrusted IP addresses
• Track database query patterns for unusual SELECT, INSERT, UPDATE, or DELETE operations originating from the application
• Review authentication logs for gaps between data access events and valid authentication sessions
• Establish baseline normal activity patterns and alert on deviations that may indicate exploitation

How to Mitigate CVE-2026-21980

Immediate Actions Required

• Apply the Oracle Critical Patch Update from January 2026 immediately to all affected Oracle Life Sciences Central Coding 7.0.1.0 installations
• Restrict network access to Oracle Life Sciences Central Coding to only trusted networks and authorized users
• Implement network segmentation to isolate healthcare applications from untrusted network zones
• Enable enhanced logging and monitoring on all Oracle Life Sciences Central Coding instances pending patch deployment

Patch Information

Oracle has addressed this vulnerability in the January 2026 Critical Patch Update. Organizations running Oracle Life Sciences Central Coding version 7.0.1.0 should apply the security patch as soon as possible. The official security advisory and patch downloads are available at the Oracle Security Alert January 2026.

Workarounds

• Place Oracle Life Sciences Central Coding behind a reverse proxy or application gateway that enforces authentication before allowing access to the application
• Implement IP-based access controls to restrict access to the Platform component from known, trusted sources only
• Deploy a web application firewall (WAF) with rules configured to block suspicious unauthenticated requests to sensitive endpoints
• Consider temporarily disabling network access to non-critical functionality until the patch can be applied

# Example: Restrict network access using iptables (Linux)
# Allow only trusted network ranges to access the application port
iptables -A INPUT -p tcp --dport 80 -s 10.0.0.0/8 -j ACCEPT
iptables -A INPUT -p tcp --dport 80 -j DROP

# Enable logging for blocked access attempts
iptables -A INPUT -p tcp --dport 80 -j LOG --log-prefix "OLSCC-BLOCKED: "